GSK (GSK) PEG Ratio: History & Chart

GSK plc (GSK)GSKGSK plc

About GSK plc

GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its extensive vaccine portfolio includes immunizations against shingles, meningitis, respiratory syncytial virus (RSV), seasonal and pandemic influenza, and polio. Beyond preventative care, GSK provides diverse therapeutic products covering critical areas such as HIV, oncology, respiratory and immunology conditions, and other specialized medical fields. This also encompasses inhaled treatments for chronic respiratory ailments like asthma and chronic obstructive pulmonary disease (COPD), along with antibiotics for various infections. Innovation at GSK is frequently driven by strategic partnerships. Notable collaborations include an agreement with CureVac to advance mRNA-based influenza vaccines, and alliances with Wave Life Sciences and Elsie Biotechnologies focused on developing oligonucleotide platforms. Furthermore, GSK has established two distinct strategic collaborations with Relation to progress therapeutics for fibrotic diseases and osteoarthritis. The company is also engaged in a multi-target strategic alliance aimed at developing pioneering treatments for individuals suffering from Parkinson's disease, and a partnership with Flagship Pioneering to identify novel medicines and vaccines.

London, GL

66,841 employees

www.gsk.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Luke Victor Miels

View full financials

GSK PEG Ratio Metrics

PEG RATIO

0.10

PEG RATIO AVG TTM

N/A

PEG RATIO AVG 3Y

0.06

PEG RATIO AVG 5Y

0.18

PEG RATIO AVG 10Y

0.26

PEG RATIO AVG 15Y

0.26

PEG RATIO AVG 20Y

0.35

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

+66.67%

CURRENT VS 5Y AVG

-43.40%

CURRENT VS 10Y AVG

-61.11%

CURRENT VS 15Y AVG

-61.86%

CURRENT VS 20Y AVG

-71.36%

SECTOR MEDIAN · HEALTHCARE

1.82

median of 49 covered companies

CURRENT VS SECTOR MEDIAN

-94.51%

vs the sector median at left

NAME	MARKET CAP	PEG RATIO	TTM	3Y	5Y
GSK plc (GSK)	$101.98B	0.10	N/A	0.06	0.18
McKesson Corporation (MCK)vs ›	$105.58B	0.46	1.11	0.76	0.58
HCA Healthcare, Inc. (HCA)vs ›	$89.08B	0.57	0.71	0.71	0.86
Medtronic plc (MDT)vs ›	$116.07B	6.72	3.73	3.73	2.72
Elevance Health Inc. (ELV)vs ›	$84.66B	2.65	7.00	4.83	3.76
CVS Health Corp. (CVS)vs ›	$119.30B	N/A	0.13	1.20	1.17
Regeneron Pharmaceuticals, Inc. (REGN)vs ›	$82.11B	3.38	2.53	2.53	1.33
Boston Scientific Corporation (BSX)vs ›	$76.09B	0.88	2.57	1.84	2.46
Bristol-Myers Squibb Company (BMY)vs ›	$129.94B	1.52	0.24	0.24	0.18
Cigna Corporation (CI)vs ›	$72.37B	0.15	0.15	0.28	0.23

NAME

MARKET CAP

PEG RATIO

TTM

GSK plc (GSK)

$101.98B

0.10

N/A

0.06

0.18

McKesson Corporation (MCK)vs ›

$105.58B

0.46

1.11

0.76

0.58

HCA Healthcare, Inc. (HCA)vs ›

$89.08B

0.57

0.71

0.86

Medtronic plc (MDT)vs ›

$116.07B

6.72

3.73

2.72

Elevance Health Inc. (ELV)vs ›

$84.66B

2.65

7.00

4.83

3.76

CVS Health Corp. (CVS)vs ›

$119.30B

N/A

0.13

1.20

1.17

Regeneron Pharmaceuticals, Inc. (REGN)vs ›

$82.11B

3.38

2.53

1.33

Boston Scientific Corporation (BSX)vs ›

$76.09B

0.88

2.57

1.84

2.46

Bristol-Myers Squibb Company (BMY)vs ›

$129.94B

1.52

0.24

0.18

Cigna Corporation (CI)vs ›

$72.37B

0.15

0.28

0.23

PEG Ratio FAQ

What is the PEG ratio for GSK plc (GSK)?

The PEG ratio for GSK stock is 0.10.

Is GSK plc's PEG ratio high or low?

The PEG ratio of 0.10 is 43% below its 5-year average of 0.18, near the low end of its 5-year range (0.02–0.41).

What is the 3Y average PEG ratio for GSK plc (GSK)?

The 3Y average PEG ratio for GSK stock is 0.06.

What is the 5Y average PEG ratio for GSK plc (GSK)?

The 5Y average PEG ratio for GSK stock is 0.18.

What is the 10Y average PEG ratio for GSK plc (GSK)?

The 10Y average PEG ratio for GSK stock is 0.26.

What is the 15Y average PEG ratio for GSK plc (GSK)?

The 15Y average PEG ratio for GSK stock is 0.26.

What is the 20Y average PEG ratio for GSK plc (GSK)?

The 20Y average PEG ratio for GSK stock is 0.35.

DATE	PEG RATIO
2025-12-31	0.10
2022-12-31	0.02
2020-12-31	0.41
2019-12-31	0.56
2018-12-31	0.12
2017-12-31	0.56
2015-12-31	0.03
2013-12-31	0.51
2011-12-31	0.05
2009-12-31	0.43
2006-12-31	0.73
2005-12-31	0.67
2003-12-31	0.80
2002-12-31	0.44
2000-12-31	0.63
1996-12-31	0.49

DATE

PEG RATIO

2025-12-31

0.10

2022-12-31

0.02

2020-12-31

0.41

2019-12-31

0.56

2018-12-31

0.12

2017-12-31

0.56

2015-12-31

0.03

2013-12-31

0.51

2011-12-31

0.05

2009-12-31

0.43

2006-12-31

0.73

2005-12-31

0.67

2003-12-31

0.80

2002-12-31

0.44

2000-12-31

0.63

1996-12-31

0.49

PEG Ratio: 0.10

GSK PEG Ratio Chart

GSK Average PEG Ratio Chart

GSK Current vs Average PEG Ratio Chart

GSK PEG Ratio Metrics

GSK Competitors' PEG Ratio

Growth-Adjusted Valuation

PEG Ratio Formula & Definition

PEG Ratio FAQ

GSK PEG Ratio History

Related Metrics